IndraLab

Statements


| 1 2

sparser
"This study describes a novel BAP1-MAFF signaling axis which is crucial for CRC growth, potentially serving as a therapeutic target and a promising prognostic biomarker for CRC."

reach
"BAP1 as a nuclear deubiquitinating enzyme (DUB), bound to and deubiquitinated MAFF, thereby stabilizing it."

sparser
"Xie et al. [ xref ], in their analysis, revealed a novel BAP1-MAFF signaling axis that may be fundamental for CRC growth and could be regarded as either a prognostic marker or a potential therapeutic target."